CNNM2 Mutations Cause Impaired Brain Development and Seizures in Patients with Hypomagnesemia

English version České info

Mental retardation affects 1–3% of the population and has a strong genetic etiology. Consequently, early identification of the genetic causes of mental retardation is of significant importance in the diagnosis of the disease, as predictor of the progress of the disease and for the determination of treatment. In this study, we identify mutations in the gene encoding for cyclin M2 (CNNM2) to be causative for mental retardation and seizures in patients with hypomagnesemia. Particularly, in patients with a recessive mode of inheritance, the intellectual disability caused by dysfunctional CNNM2 is dramatically severe and is accompanied by severely limited motor skills and brain malformations suggestive of impaired early brain development. Although hypomagnesemia has been associated to several neurological diseases, Mg2+ status is not regularly assessed in patients with seizures and mental disability. Our findings establish CNNM2 as an important protein for renal magnesium handling, brain development and neurological functioning, thus explaining the physiology of human disease caused by (dysfunctional) mutations in CNNM2. CNNM2 mutations should be taken into account in patients with seizures and mental disability, specifically in combination with hypomagnesemia.

Vyšlo v časopise: CNNM2 Mutations Cause Impaired Brain Development and Seizures in Patients with Hypomagnesemia. PLoS Genet 10(4): e32767. doi:10.1371/journal.pgen.1004267
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004267

Souhrn

Zdroje

1. DimkeH, MonnensL, HoenderopJG, BindelsRJ (2012) Evaluation of Hypomagnesemia: Lessons From Disorders of Tubular Transport. Am J Kidney Dis 62: 377–83.

2. MoserJ, KilbW, WerhahnKJ, LuhmannHJ (2006) Early developmental alterations of low-Mg2+ -induced epileptiform activity in the intact corticohippocampal formation of the newborn mouse in vitro. Brain Res 1077: 170–177.

3. JinJ, WuLJ, JunJ, ChengX, XuH, et al. (2012) The channel kinase, TRPM7, is required for early embryonic development. Proc Natl Acad Sci USA 109: E225–E233.

4. van de GraafSF, BindelsRJ, HoenderopJG (2007) Physiology of epithelial Ca2+ and Mg2+ transport. Rev Physiol Biochem Pharmacol 158: 77–160.

5. RunnelsLW (2011) TRPM6 and TRPM7: A Mul-TRP-PLIK-cation of channel functions. Curr Pharm Biotechnol 12: 42–53.

6. HoenderopJG, BindelsRJ (2008) Calciotropic and magnesiotropic TRP channels. Physiology 23: 32–40.

7. ThebaultS, AlexanderRT, Tiel GroenestegeWM, HoenderopJG, BindelsRJ (2009) EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol 20: 78–85.

8. VoetsT, NiliusB, HoefsS, van der KempAW, DroogmansG, et al. (2004) TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem 279: 19–25.

9. StuiverM, LainezS, WillC, TerrynS, GunzelD, et al. (2011) CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypomagnesemia. Am J Hum Genet 88: 333–343.

10. de BaaijJH, Groot KoerkampMJ, LavrijsenM, van ZeelandF, MeijerH, et al. (2013) Elucidation of the distal convoluted tubule transcriptome identifies new candidate genes involved in renal magnesium handling. Am J Physiol Renal Physiol 305: F1563–73 doi:10.1152/ajprenal.00322.2013

11. GoytainA, QuammeGA (2005) Functional characterization of ACDP2 (ancient conserved domain protein), a divalent metal transporter. Physiol Genomics 22: 382–389.

12. de BaaijJH, StuiverM, MeijIC, LainezS, KopplinK, et al. (2012) Membrane topology and intracellular processing of cyclin M2 (CNNM2). J Biol Chem 287: 13644–13655.

13. WangCY, ShiJD, YangP, KumarPG, LiQZ, et al. (2003) Molecular cloning and characterization of a novel gene family of four ancient conserved domain proteins (ACDP). Gene 306: 37–44.

14. RipkeS, SandersAR, KendlerKS, LevinsonDF, SklarP, et al. (2011) Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43: 969–976.

15. Newton-ChehC, JohnsonT, GatevaV, TobinMD, BochudM, et al. (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41: 666–676.

16. HwangP-P, ChouM-Y (2013) Zebrafish as an animal model to study ion homeostasis. Pflügers Arch 465: 1233–1247.

17. LieschkeGJ, CurriePD (2007) Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8: 353–367.

18. ArjonaFJ, ChenYX, FlikG, BindelsRJ, HoenderopJG (2013) Tissue-specific expression and in vivo regulation of zebrafish orthologues of mammalian genes related to symptomatic hypomagnesemia. Pflügers Arch 465: 1409–1421.

19. WalderRY, LandauD, MeyerP, ShalevH, TsoliaM, et al. (2002) Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 31: 171–174.

20. SponderG, SvidovaS, SchweigelM, VormannJ, KolisekM (2010) Splice-variant 1 of the ancient domain protein 2 (ACDP2) complements the magnesium-deficient growth phenotype of Salmonella enterica sv. typhimurium strain MM281. Magnes Res 23: 105–114.

21. WhiteJR, CameronAE (1948) The Natural Abundance of Isotopes of Stable Elements. Phys Rev 74: 991–1000.

22. ChokshiR, FruasahaP, KozakJA (2012) 2-aminoethyl diphenyl borinate (2-APB) inhibits TRPM7 channels through an intracellular acidification mechanism. Channels 6: 362–369.

23. WhittamR, WheelerKP (1961) The sensitivity of a kidney ATPase to ouabain and to sodium and potassium. Biochim Biophys Acta 51: 622–624.

24. KolisekM, NestlerA, VormannJ, Schweigel-RontgenM (2012) Human gene SLC41A1 encodes for the Na+/Mg(2)+ exchanger. Am J Physiol Cell Physiol 302: C318–C326.

25. GoytainA, QuammeGA (2005) Identification and characterization of a novel mammalian Mg2+ transporter with channel-like properties. BMC Genomics 6: 48.

26. MahmoodF, MozereM, ZdebikAA, StanescuHC, TobinJ, et al. (2013) Generation and validation of a zebrafish model of EAST (epilepsy, ataxia, sensorineural deafness and tubulopathy) syndrome. Dis Model Mech 6: 652–660.

27. Saint-AmantL, DrapeauP (1998) Time course of the development of motor behaviors in the zebrafish embryo. J Neurobiol 37: 622–632.

28. ElizondoMR, ArduiniBL, PaulsenJ, MacDonaldEL, SabelJL, et al. (2005) Defective skeletogenesis with kidney stone formation in dwarf zebrafish mutant for trpm7. Curr Biol 15: 667–671.

29. LowSE, AmburgeyK, HorstickE, LinsleyJ, SpragueSM, et al. (2011) TRPM7 is required within zebrafish sensory neurons for the activation of touch-evoked escape behaviors. J Neurosci 31: 11633–11644.

30. VeltmanJA, BrunnerHG (2012) De novo mutations in human genetic disease. Nat Rev Genet 13: 565–575.

31. HodgkinsonA, Eyre-WalkerA (2011) Variation in the mutation rate across mammalian genomes. Nat Rev Genet 12: 756–766.

32. ThisseB, ThisseC (2004) Fast Release Clones: A High Throughput Expression Analysis. ZFIN Direct Dat Submission (http://zfin.org).

33. Scholpp S, Brand M (2009) Neural Patterning: Midbrain–Hindbrain Boundary. In: Larry RS, editor. Encyclopedia of Neuroscience. Oxford: Academic Press. pp. 205–211.

34. DworkinS, JaneSM (2013) Novel mechanisms that pattern and shape the midbrain-hindbrain boundary. Cell Mol Life Sci 70: 3365–3374.

35. JinJ, WuLJ, JunJ, ChengX, XuH, et al. (2012) The channel kinase, TRPM7, is required for early embryonic development. Proc Natl Acad Sci USA 109: E225–E233.

36. KrapivinskyG, MochidaS, KrapivinskyL, CibulskySM, ClaphamDE (2006) The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron 52: 485–496.

37. BrauchiS, KrapivinskyG, KrapivinskyL, ClaphamDE (2008) TRPM7 facilitates cholinergic vesicle fusion with the plasma membrane. Proc Natl Acad Sci USA 105: 8304–8308.

38. HildebrandtF, HeeringaSF, RüschendorfF, AttanasioM, NürnbergG, et al. (2009) A systematic approach to mapping recessive disease genes in individuals from outbred populations. PLOS Genet 5: e10000353.

39. GkikaD, MahieuF, NiliusB, HoenderopJG, BindelsRJ (2004) 80K-H as a new Ca2+ sensor regulating the activity of the epithelial Ca2+ channel transient receptor potential cation channel V5 (TRPV5). J Biol Chem 279: 26351–26357.

40. EisenJS, SmithJC (2008) Controlling morpholino experiments: don't stop making antisense. Development 135: 1735–1743.